{"id":"W4387809673","doi":"10.1016/j.annonc.2023.10.029","title":"LBA9 innovaTV 301/ENGOT-cx12/GOG-3057: A global, randomized, open-label, phase III study of tisotumab vedotin vs investigator’s choice of chemotherapy in 2L or 3L recurrent or metastatic cervical cancer","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Hospital","funders":"Ipsen; Astellas Pharma; Eisai; AstraZeneca; University College London; Boston Scientific Corporation; Seagen; Pfizer","keywords":"Medicine; Open label; Chemotherapy; Oncology; Internal medicine; Phases of clinical research; Open label study; Surgery; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002007619,0.001513628,0.002310834,0.000495732,0.0004062653,0.001245566,0.001182051,0.001811666,0.008069461],"category_scores_gemma":[0.001069282,0.0006173192,0.001918491,0.0004752482,0.001459671,0.001276118,0.0004553771,0.004873838,0.001617266],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00135416,"about_ca_system_score_gemma":0.001760883,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002508032,"about_ca_topic_score_gemma":0.008248091,"domain_scores_codex":[0.9993894,0.0003036924,0.00001778078,0.0001082087,0.00004644113,0.0001344828],"domain_scores_gemma":[0.9993747,0.0001495904,0.0001181585,0.00004615914,0.00003632278,0.0002750875],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9131043,0.0165171,0.001232368,0.0007845598,0.001480555,0.00004041035,0.0001048202,0.001094514,0.005788245,0.0004079475,0.004552074,0.05489313],"study_design_scores_gemma":[0.8999537,0.09366112,0.002218749,0.00005121295,0.0005487172,0.00003849646,0.00005737882,0.000921519,0.0006028158,0.0002893682,0.001629229,0.00002763828],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9794207,0.005677275,0.001271282,0.001611542,0.0008069947,0.003105356,0.002653163,0.0003316179,0.005122114],"genre_scores_gemma":[0.9821548,0.002565328,0.002373127,0.002177122,0.0003326331,0.00270686,0.002461651,0.0000928688,0.00513553],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008069461,"threshold_uncertainty_score":0.026995,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3080902739800833,"score_gpt":0.5448928587729979,"score_spread":0.2368025847929145,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}